Symptomtext
Persistent redness right deltoid area (area of injection) more than 72 hours after injection; Redness tracks to right axilla; swelling and fullness in right axilla; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient. A 59 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 02Oct2021 14:15 (Lot number: 301358) at the age of 59 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: NAPROXEN. Vaccination history included: Bnt162b2 (Prev dose product: COVID 19, prev dose brand: Pfizer, prev dose brand unknown: False, prev dose lot number: EL9269, prev dose lot unknown: False,, prev dose administrator route: intramuscular, prev dose administration date: 05Feb2021, prev dose dose number:2, prev dose vaccine location:Right, arm.), administration date: 05Feb2021, when the patient was 59 years old, for Covid-19 immunization; Bnt162b2 (prev dose product: COVID 19, prev dose brand: Pfizer, prev dose brand unknown: False, prev dose lot number: EL3248, prev dose lot unknown: False,, prev dose administrator route: Intramusular, prev dose administration date: 15Jan2021, prev dose dose number 1, prev dose vaccine location: Right arm.), administration date: 15Jan2021, when the patient was 59 years old, for Covid-19 immunization. The following information was reported: VACCINATION SITE ERYTHEMA (non-serious) with onset 03Oct2021 02:30, outcome "not recovered", described as "Persistent redness right deltoid area (area of injection) more than 72 hours after injection"; ERYTHEMA (non-serious) with onset 03Oct2021 02:30, outcome "not recovered", described as "Redness tracks to right axilla"; SWELLING (non-serious) with onset 03Oct2021 02:30, outcome "not recovered", described as "swelling and fullness in right axilla". Therapeutic measures were not taken as a result of vaccination site erythema, erythema, swelling. Additional information: No known allergies, Post vaccination patient was not tested for COVID. Prior to vaccination patient had no COVID. Patient had no other medical history. Facility type Vaccine: Pharmacy or Drug Store. If other vaccine in four weeks: No No follow-up attempts are possible. No further information is expected. Follow-Up (13Oct2021): Follow-up attempts are completed. No further information is expected.